Mutations in the human receptor tyrosine kinase ROR2 are associated with Robinow syndrome (RRS) and brachydactyly type B1. Amongst others, the shortened limb phenotype associated with RRS is recapitulated in Ror2 −/− mutant mice. In contrast, 
| INTRODUCTION
The two receptors Ror1 and Ror2 both interact with the Wnt5a ligand resulting in phosphorylation of the intracellular molecule dishevelled (Endo, Doi, Nishita, & Minami, 2012; Sato, Yamamoto, Sakane, Koyama, & Kikuchi, 2010) . Mice lacking the orphan receptor Ror2 develop an embryonic skeletal dysplasia phenotype, with severe shortening of the long bones of the appendicular skeleton with a proximal-distal emphasis (DeChiara et al., 2000; Takeuchi et al., 2000) . The related orphan receptor Ror1 appears to play a minor role in embryonic development. There are two different published Ror1 alleles (Ho et al., 2012; Nomi et al., 2001) . Homozygous mutant mice for either of the two Ror1 alleles are viable, and their long bones develop normally until birth (Ho et al., 2012; Lyashenko et al., 2010) . The two Ror1 alleles differ as follows: The allele generated in the laboratory of Dr Minami (Nomi et al., 2001 ) produces two transcripts, one lacks exons 3 and 4 and possesses an early termination codon due to a frame-shift in exon 5. The other one lacks only exon 3 and produces a truncated Ror1 protein with a 96 a.a. deletion in its immunoglobulin (Ig)-like domain. The latter can still bind Wnt5a and subsequently induce phosphorylation of dishevelled, but to a lesser extent than the wild-type form (Qi, Okinaka, Nishita, & Minami, 2016) . As such, this allele is predicted to be a hypomorphic allele (referred to in the following as Ror1 hyp ).
The second allele is a true protein null allele and was generated in the laboratory of Dr Greenberg (Ho et al., 2012) . Double-mutant mice for both receptors, Ror1 (hypomorphic as well as null allele) and Ror2, develop more a severe phenotype, which resembles the loss of the Wnt ligand, Wnt5a, in several aspects (Ho et al., 2012; Nomi et al., 2001) . As double mutants with the Ror1 null allele die at or soon after E13.5, long bone development has only been analyzed in the Ror2 −/− ;Ror1 hyp/hyp mutants. Here, the skeletal dysplasia phenotype of the proximal long bones in the stylopod region, such as humerus (forelimb) and femur (hindlimb), is very pronounced and resembles that of Wnt5a −/− mutants. The more distal zeugopod elements (radius and ulna in the forelimb, and tibia and fibula in the hindlimb) and the autopod skeletal elements are affected to a lesser extent compared to Wnt5a −/− mutants (Nomi et al., 2001; Yamaguchi, Bradley, McMahon, & Jones, 1999; Yang, Topol, Lee, & Wu, 2003) . Recessive mutations in human ROR2 have been linked to Robinow syndrome that compromises amongst others dysmorphic facial features, short stature and brachydactyly (Afzal & Jeffery, 2003; Afzal et al., 2000; Brunetti-Pierri et al., 2008; Mehawej et al., 2012; Patton & Afzal, 2002; Tufan et al., 2005; van Bokhoven et al., 2000) . In some patients, cleft lip/cleft palate phenotypes have been reported (Brunetti-Pierri et al., 2008; Roifman, Brunner, Lohr, Mazzeu, & Chitayat, 2015; Wang et al., 2012 (He et al., 2008; Schwabe et al., 2004) . Wnt5a and Ror2 have been associated with the noncanonical planar cell polarity Wnt-signaling pathway (Gao et al., 2011) . Furthermore, it has been proposed that Wnt5a signaling through Ror2 counteracts the Wnt/β-catenin pathway (Mikels, Minami, & Nusse, 2009; Mikels & Nusse, 2006; Topol et al., 2003; van Amerongen, Fuerer, Mizutani, & Nusse, 2012) . Variations in numerous human WNT genes have also been associated with nonsyndromic cleft lip/cleft palate (Andrade Filho et al., 2011; Chiquet et al., 2008; Li et al., 2015; Menezes et al., 2010; Mostowska et al., 2012) . Tetra-amelia is caused by homozygous mutations in the WNT3 gene, a syndrome associated with the absence of all four limbs and craniofacial anomalies, amongst them cleft lip/cleft palate (Niemann et al., 2004) . The aetiology of cleft lip/cleft palate is a multifactorial trait with complex interactions of genetic and environmental risk factors (Jugessur & Murray, 2005; Watkins, Meyer, Strauss, & Aylsworth, 2014) . Based on the phenotypic and molecular analyses, Ror2 has primarily been implicated as a receptor for Wnt5a in noncanonical signaling. In this study, we analyzed the potential genetic interaction between mutants for the Wnt ligand, Wnt9a (formerly known as Wnt14), and the Ror receptors, Ror1 and Ror2, focusing on the limb skeleton and the palate. Wnt9a is expressed in the developing joints and the perichondrium and has been implicated to play a role in joint development (Guo et al., 2004; Hartmann & Tabin, 2001) . Wnt9a mutants display a slight shortening of the long bones at birth due to a temporal down-regulation in Indian hedgehog (Ihh) expression from E12.5 to E13.5 (Spater et al.., 2006 
| RESULTS AND DISCUSSION
To address a possible interaction between the receptor Ror2 and the Wnt ligand, Wnt9a, we generated double and compound mutants. Loss of one copy of Ror2 in the Wnt9a homozygous mutant background (Ror2 Figure   1Af compared to Bc). Phenotypically, the limbs resembled the Wnt5a mutant phenotype in the stylopod (humerus, femur) and zeugopod (radius and ulna, tibia and fibula), but not in the autopod and digit region ( Figure 1Af ) (Yamaguchi et al., 1999) . Particularly, the endochondral ossification process in the zeugopods of Ror2 Figure 1Af compare to Bc). The phenotypic alterations in the hindlimb were similar (data not shown). Ror1 hyp/hyp mutants show no skeletal phenotype with respect to their long bones at birth (Figure 1Cb ) (Lyashenko et al., 2010) , and Wnt9a −/− mutants display only a slight shortening (Figure 1Cc ) (Spater et al., 2006 Figure 1 Ca and data not shown). Hence, given our phenotypic analysis of the limb skeleton, we conclude that the downstream pathways of Ror2 and Wnt9a, and Ror1 and Wnt9a converge and act synergistically on the process of chondrocyte maturation. Based on evidence from the literature, we hypothesized that the two signaling pathways Ror2 and Wnt9a might possibly converge at the level of Ihh regulation. We have shown before that Wnt9a temporarily regulates Ihh expression at around E12.5-E13.5 and at least at E15.5 Ihh is severely reduced in the stylopod of Ror2 mutants (Schwabe et al., 2004; Spater et al., 2006) . In order to further investigate this, we carried out a temporal expression analysis from E11.5 to E15.5 on Ror2 at E11.5, but it was down-regulated at E12.5-E13.5 in the humerus ( Figure 2A ). At E14.5, Ihh expression was detected in 50% of the Ror2 mutant stylopods analyzed and absent in the other 50% (n = 4; Figure 2A ). Similar to the Ror2 −/− mutants, the onset of Ihh expression also occurred normally at E11.5 in the Ror2
;Wnt9a −/− double mutants ( Figure 2B ).
Yet, at E13.5 Ihh expression was even further reduced than in the Ror2 mutant (compare Figure 2A,C) . Histologically, no signs of hypertrophy were detected on alcian blue-stained sections, and accordingly, no signals were detected for the Col10a1 in situ probes normally marking hypertrophic chondrocyte differentiation ( Figure 2C ). Ihh expression levels (Figure 3Ba,a' ). The latter developed as the wild-type newborns (data not shown). Marker analysis for hypertrophic chondrocytes (Col10a1) and osteoblasts (collagen 1a1 (Col1a1) and osteocalcin (Oc)) was carried out on P0 humeri of the different mutants. In reported with regard to long bone growth (Lyashenko et al., 2010; Nomi et al., 2001 ). The Ror1 null allele mutants have not yet been characterized in detail, but they are viable and do not display any obvious morphological phenotypes at birth (Ho et al., 2012) . As such, compensatory mechanisms mediated by Ror2 might account for the lack of an embryonic phenotype of Ror1 mutants. Similar to the previous publication showing a compensatory mechanism between Ror1 and Ror2 (Nomi et al., 2001) , our data suggest that Ror1 signaling may in part compensate for the loss of Wnt9a, as the skeletal preparations of the limbs showed a more severe phenotype in the double mutants compared to the single mutants ( Figure  1C ). Furthermore, when examining the whole-mount skeletal preparations a cleft secondary palate phenotype was observed in the Ror1 hyp/hyp ;Wnt9a −/− mutants (n = 3) ( Figure 4A ).
Neither Ror1 mutants nor Wnt9a −/− single mutants display a cleft palate phenotype (Ho et al., 2012; Lyashenko et al., 2010; Nomi et al., 2001; Spater et al., 2006 ). Yet, in zebrafish Wnt9a is required for palatal extension during palatal morphogenesis and an incompletely penetrant cleft palate phenotype was reported in mouse mutants lacking the closely related family member Wnt9b (formerly known as Wnt15) (Carroll, Park, Hayashi, Majumdar, & McMahon, 2005; Curtin, Hickey, Kamel, Davidson, & Liao, 2011; Dougherty et al., 2013; Jin, Han, Taketo, & Yoon, 2012) . In addition, the recessive knockout Wnt9b allele is allelic to the clf1 locus of the A/ WySn strain that models the human defect (Juriloff, Harris, McMahon, Carroll, & Lidral, 2006) . Further analysis of the clf1 region uncovered that an intracisternal A particle (IAP) retrotransposon was inserted near the Wnt9b gene. Associated epigenetic alterations at the mouse Wnt9b gene locus lead to altered Wnt9b expression levels and contribute to the phenotype of the A/WySn strain (Juriloff, Harris, Mager, & Gagnier, 2014) . Polymorphisms in the human WNT9B homologue have also been associated with nonsyndromic cleft lip/cleft palate (Fontoura, Silva, Granjeiro, & Letra, 2015 Figure 4B-D) . The phenotype is not linked to the sex of the mice. Interestingly, it has been proposed that the cleft secondary palate phenotype in the Ror2 −/− mutants is in part due to a down-regulation of the expression of another hedgehog family member, sonic hedgehog (Shh), in the medial edge epithelium and altered cell proliferation in the mesenchyme of the anterior palate particular in the nasal aspect (He et al., 2008) . Ror2 has been implicated to act as the receptor for Wnt5a in palate shelf formation. Yet, the phenotype of the Ror2 mutant is less severe than that of the Wnt5a mutant with respect to the posterior region (He et al., 2008) . Our finding in the compound mutants suggests that in analogy to the situation in the limb Ror1 might act as a receptor for Wnt5a in addition to Ror2 during palatogenesis. Given that two transcripts can be generated from the hypomorphic Ror1 allele, one producing a truncated Ror1 protein and one producing no protein, it is possible that the Ror2 ) and of Ror2 −/− mutant embryos (see Figure 4F ). Size measurements could only be carried out on two samples of each genotype; hence, we can currently only state that there is a clear trend for a size reduction of the anterior palate in the Ror2 According to a previous publication, Ror2 is expressed in an anterior to posterior graded fashion in the epithelium and mesenchyme of the palate, with the anterior mesenchymal domain being restricted to the medial region (He et al., 2008) . In our hands, at E13.5, Ror2 expression was restricted to the mesenchyme of the palatal shelf in a nongraded fashion and is expressed highest underneath the ectoderm ( Figure 4E ). Ror1 expression was also detected in the palatal mesenchyme ( Figure 4E ). Yet, no distinct Wnt9a expression was detected in the palatal shelf at E13.5 ( Figure 4E ). In the anterior-most region Wnt9a was weakly expressed in the incisor region ( Figure  4E ). Interestingly, Wnt9b expression is also not detected in the secondary palate throughout its development, but Wnt9b is expressed earlier in the midfacial ectoderm (Lan et al., 2006) .
Co-immunoprecipitation of extracts from HEK cells coexpressing Wnts and Ror1 or Ror2 showed that Wnt9a interacted with both Ror receptors Ror1 and Ror2, as did Wnt3a, Wnt5a and Wnt9b ( Figure 5A ). As in the Ror1 hyp mice, a truncated protein lacking the immunoglobulin (Ig)-like domain is still produced, we tested whether Wnt9a, like Wnt5a, can still interact with the Ror1∆Ig form. Indeed, Wnt9a, like Wnt5a, was able to bind to the Ror1∆Ig protein, but both Wnt ligands failed to interact with Ror1 and Ror2 proteins lacking the cysteine-rich, extracellular domain (∆CRD) ( Figure 5B ,C). Taken together, our results suggest that mutations in WNT9A and ROR1 may be additional risk factors for nonsyndromic cleft lip/cleft palate and combinatorial modulators of long bone growth. Mutations in these genes may not easily be identified by genome-wide association studies as risk factors, because this would require sufficiently large pedigrees for statistical power or combining GWAS with other analytical methods to detect such compound genetic risk factors (Mooney, Nigg, McWeeney, & Wilmot, 2014; Weiss et al., 2012; Wittkowski et al., 2013) .
| EXPERIMENTAL PROCEDURES

| Mouse husbandry
The generation of the Ror1, Ror2 and Wnt9a mutant alleles has been previously described (Ho et al., 2012; Nomi et al., 2001; Spater et al., 2006; Takeuchi et al., 2000) . Ror1 and Ror2 strains were maintained on a C57BL/6J background. Mutants were generated by intercrosses of heterozygous mice, or through breeding of homozygous males with heterozygous females to increase the number of mutant offspring. Genotyping of newborn mice and embryos by PCR was carried out as previously described for Ror1 (Lyashenko et al., 2010) and Ror2 (Schwabe et al., 2004) , and for Wnt9a, the following primer sequences were used: Wnt9a_For1: 5′-GCGAGGTAAGCTCTGCTTGCCTCC-3′, Wnt9a_For2: 5′-GCTCTGATGCCGCCGTGTTCC-3′, Wnt9a_Rev: 5′-CGA GGCTTTCGGTCAAAGCTGATGG-3′ amplifying a 100-bp wild-type and an 1,100-bp mutant allele. The E13. 
| Whole-mount skeletal preparations
Newborn pups (P0) and embryos were skinned, eviscerated and fixed in 95% EtOH. Skeletons were stained with alizarin red and alcian blue for mineralized and cartilaginous regions, respectively (McLeod, 1980) , and cleared through serial processing with 1% KOH, 1% KOH:glycerol (3:1; 1:1; 1:3) into pure glycerol.
| Histology and in situ hybridization
For histology and section in situ hybridizations, embryos and newborns were fixed overnight in 4% PFA/PBS and dehydrated to 100% EtOH. Newborns were skinned before fixation. Limbs were removed in 75% EtOH and processed into paraffin. Mutant and wild-type limbs were embedded into the same paraffin block, and alternating sections at 6 µm were generated. Sections processed for van Kossa/alcian blue stainings were deparaffinized and rehydrated into H 2 O. Mineralization was visualized by incubation of sections in 2% silver nitrate solution under light exposure (60-W bulb) for 1 hr. For subsequent cartilage matrix visualization, sections were washed with 1% acetic acid and stained for 15 min in alcian blue staining solution (20 mg alcian blue in 70 ml EtOH, 30 ml acetic acid, filtered). Before dehydration and mounting with DPX (Sigma), the tissue was counterstained with eosin. Nonradioactive section in situ hybridizations using digoxigenin-labeled RNA probes were carried out according to Murtaugh, Zeng, Chyung, and Lassar (2001) . Probes for Ihh, Col10a1, Col2a1, Col1a1, Osc (Hill, Spater, Taketo, Birchmeier, & Hartmann, 2005) , Ror2, Ror1 (Oishi et al., 1999) , and Wnt9a (Kahn et al., 2009 ) have been previously published and are available on request.
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| Plasmids
Plasmids encoding Flag-tagged mouse Ror1 and Ror2 and their derivative deletion mutants were constructed as described (Matsuda et al., 2003; Oishi et al., 2003; Qi et al., 2016) . Wnt9a and Wnt5a hemagglutinin (HA)-tagged expression plasmids were generated by inserting the coding regions of Wnt9a and Wnt5a first into the phCMV3 vector (Genlantis) containing a C-terminal HA-tag. Subsequently, the tagged cDNAs were cloned into a modified pCAAGS vector (Niwa, Yamamura, & Miyazaki, 1991) containing, in addition, a PGK-neo cassette for selection in mammalian cells.
| Co-immunoprecipitation
HEK293T cells were cultured in DMEM containing 10% (v/v) fetal calf serum and transiently cotransfected with Wnt-HA and Ror-Flag expression plasmids using Lipofectamine 2000 (Life Technologies) according to the manufacturer's instruction. At 24 hr after transfection, cells were solubilized with lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 0.5% (v/v) NP-40, 50 mM NaF, 1 mM Na 3 VO 4 , 10 µg/ml leupeptin, 10 µg/ml aprotinin, 0.25 mM pAPMSF) and centrifuged at 12,000 g for 20 min. Whole cell lysates were subjected to immunoprecipitation with an anti-HA antibody (16B12, Covance), followed by Western blotting with anti-Flag (1E6, Wako) and anti-HA (3F10, Roche) antibodies. 
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